Invention Grant
- Patent Title: GLUT4 endocytosis inhibitor
-
Application No.: US15111545Application Date: 2015-01-16
-
Publication No.: US10251897B2Publication Date: 2019-04-09
- Inventor: Tomoyuki Nishizaki
- Applicant: NISHIZAKI BIOINFORMATION RESEARCH INSTITUTE
- Applicant Address: JP Kobe
- Assignee: NISHIZAKI BIOINFORMATION RESEARCH INSTITUTE
- Current Assignee: NISHIZAKI BIOINFORMATION RESEARCH INSTITUTE
- Current Assignee Address: JP Kobe
- Agency: Leydig, Voit & Mayer, Ltd.
- Priority: JP2014-007232 20140117
- International Application: PCT/JP2015/051022 WO 20150116
- International Announcement: WO2015/108134 WO 20150723
- Main IPC: A61K31/685
- IPC: A61K31/685
Abstract:
The present invention provides a therapeutic drug for diabetes containing 1,2-dioleoyl-sn-glycerol-3-phosphoethanolamine (DOPE) as an active ingredient, particularly a therapeutic drug for diabetes that exhibits a GLUT4 endocytosis suppressive action by suppressing activation of PKCα and the like.
Public/Granted literature
- US20160331769A1 GLUT4 ENDOCYTOSIS INHIBITOR Public/Granted day:2016-11-17
Information query
